||EPS - Basic
||Market Cap (m)
Real-Time news about Progressive Dig (London Stock Exchange): 0 recent articles
|wiganer: I think you're being a tad harsh. Looking at the share price on 21st March he probably paid around same as placing price, and the rocketing of the price beyond the placing price could not be a cert- many companies see their price depressed when they do a placing.|
|omlaysause: Hey Ken, how's you doing??
Bring back the old IBG share price days eh!?? LOL!
I don't know if Maz still has any holdings, I remember he sold a fair few after the IBG-TMN thing.
Do you still hold these, I decided to give it another 24 months, so 18 months to go.|
|omlaysause: Would be even better if we could get the old share price back together!|
|fragilelittlepetal: Oiht is right - but there was a dilution of about 5 to 1 (ish) .... so although the share price is exactly the same, the company has to have a market cap of 5x the value of TMN.
Has anyone got any views on a phrase in the annual report ... something about adopting a "more traditional debt to equity position". Does this mean that the debt will be capitalised (and we'll be further diluted) - or even push Mr Danson over the 90% threshold to take it private...
Been a shareholder for almost a decade now, for better and worse ... it would be good to think we're not going to get taken out just when the share price started to perform again.
Information's a bit sketchy - releases aren't exactly thick on the ground?!?|
|monkeyman2: Typically I sold mine about a month after needing the money for other things.
If anyone wants a share price to rise let me know and I'll sell mine.
Good luck to current holders and I suspect the now lesser competition due to the demise of DGM will help PRO along.|
|old father time: The position here won't be clear until well into next year.
There'll be almost meaningless interims to June released next month, hopefully with some helpful comment on current trading. There'll be a pre-close update at the end of the year followed by the results for the six months to December 2009 in March 2010. By this stage there might begin to be a picture of how things are settling in.
This is a new business and it will take time for the longer term picture to emerge.
In the meantime the share price will be going nowhere.
The only thing which might liven things up is M&A activity.|
|andrbea: last post on iii board:
"I have been aware of this company for a couple of years as TMN when trading around 70p.
Bought straight into it when it came back on after merging with Progressive Digital Media.
I'm very surprised the share price has remained around the 12p/13p range.
Directors buying at 12.5 does not surprise me.
It looks an excellent buy at that price. "
Some other stuff
ceo holds ca 84% of the equity (315m shares)
New business valued (see below) at much higher level than current mkt cap (9m):
The new business is expected to have a market capitalisation of £38.8million
Monday June 22,2009 Daily Express
By Phillip Waller
A GO-AHEAD business-to-business publisher is looking to create a conferencing and marketing powerhouse set to be worth just under £40million by reversing into a struggling online marketing firm.|
|old father time: Omlaysause,
If you held one TMN share last week you now own one PRO share - all that's changed is the name. Danson has sold TMN his businesses in return for which he's received shares. Whether TMN shareholders or Danson have gained by this is anybody's guess.
The fact remains that if you held one share in TMN a year ago and still hold you have one share in PRO today valued at around 12p.|
|rmart: the update in june stated :
Provalis plc (LSE: PRO; NASDAQ: PVLS), the international medical diagnostics and
pharmaceuticals group, is today providing a year-end trading review and an
update on the roll out of its new in2it(TM) diagnostics product.
The supply of analysers and commissioning of automated cartridge manufacturing
for the Group's flagship product, in2it(TM), has gone well. However, as is
common with new product development in such complex technologies, the Group has
encountered several "teething problems" with both the analyser and the A1c test
cartridge. These have necessitated a number of enhancements to improve
significantly the performance and robustness of the product which will also
enhance its competitive position.
The Board decided to implement and validate all of the enhancements before
larger quantities of the cartridges are shipped to the US. Production of the
upgraded analyser has now resumed and the improved cartridge will follow
shortly, targeting a full US roll-out of in2it during the early Summer. The
interest in the product and demand for the A1c cartridge remain strong.
in August the new CE said :
Peter Woodford, commented;
"As I said when I joined the Group in July, I'm particularly excited by the
commercial potential of in2itTM, our flagship A1c diabetes testing product.
With the US launch of in2it well underway, I am confident that our diagnostics
business is now set for growth."
In October results it was stated :
The prospects for the Medical Diagnostics business remain encouraging. Shipment
to the USA only recommenced in July 2005, and despite positive feedback from
early users of these products, it is too early to predict how successful the
product will be in the year ahead.
The in2it(TM) analyser as a platform can be used to run a number of tests. The
Group is evaluating further tests and development of the first, for high
sensitivity c-reactive protein, is progressing.
The Medical Diagnostics business' full focus is on the direct selling of
in2it(TM) A1c to the USA, as that is where its ultimate success will be
determined. The Group remains committed to delivering the quality product needed
to achieve this.
At no point have Provalis intimated that sales are not going as well as expected. IMO they are keeping the cards close to their chest on sales figures as they have said for 'competitive reasons'
I think we will see better than expected sales and I also think the current drop in price is down to the USA shares returning to UK. I also think there will bne a correction in the share price to around 5p when the USA shares are absorbed here, and when (and if) good news is released on sales of in2it we will be back up into double figures.
ALL IMO OF COURSE, DYOR.|
|zedder: I'll retract the serial deramper comment then trotting. As someone sensibly said in a post earlier this week, it is not at all unusual to have the sort of teething problems PRO have had when bringing a new product to market. As I've said before, my biggest worry with PRO is that one of the big boys will have been watching everything from the sidelines. Why invest their own money in bringing a major (and I believe this is major) new product to the market, when they can watch a tiddler absorb all the pain and expense and then snap them up for a bargain price once the product is in service and proven to be in high demand. After the way the PRO share price has behaved over the last couple of years, I think if they offered to buy the company at the last placing price of 11.25p (PRO raised £10m in early 2002), then everyone would happily grab at such a price, and the big boy would have grabbed themselves a bargain. A lot of money has been used by this company bringing it's products to market, but PRO still now only has a Mkt Cap of only just under £15m.|
Progressive Dig share price data is direct from the London Stock Exchange